The Medicines Company meets the demands of the world's most advanced medical practitioners by developing products that improve acute hospital care. The Company markets Angiomax (bivalirudin) for injection; an anticoagulant approved for use in patients undergoing coronary angioplasty procedures. The Medicines Company creates value using its range of clinical and commercial skills to develop products acquired from leading life science innovators.
Discover specific contacts and email addresses at The Medicines Company.
Request a full profile of The Medicines Company with decision maker contacts and email address: